Pityriasis rosea during COVID-19: Pathogenesis, diagnosis, and treatment
- PMID: 35233812
- PMCID: PMC9088590
- DOI: 10.1002/jmv.27672
Pityriasis rosea during COVID-19: Pathogenesis, diagnosis, and treatment
Conflict of interest statement
The authors declare no conflictS of interest.
Comment on
-
Can COVID-19 cause atypical forms of pityriasis rosea refractory to conventional therapies?J Med Virol. 2022 Apr;94(4):1292-1293. doi: 10.1002/jmv.27535. Epub 2021 Dec 31. J Med Virol. 2022. PMID: 34931329 No abstract available.
References
-
- Drago F, Ranieri E, Malaguti F, Battifoglio ML, Losi E, Rebora A. Human herpesvirus 7 in patients with pityriasis rosea. Electron microscopy investigations and polymerase chain reaction in mononuclear cells, plasma and skin. Dermatology. 1997;195:374‐378. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical